ArticleRMD open2024

Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial.

Nathan den Broeder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.